HIV/AIDS Clinical Trials in Chicago

Showing 321-340 of 648 trials

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure

NCT02263326

HIV-1 infected subjects with CD4 nadir \> 200 cells/mm3, no history of virologic failure and plasma HIV RNA \<50 copies/mL for at least 48 weeks while on any United States Department of Health and Human Services (DHHS) recommended or alternative three-drug antiretroviral regimen will be randomized to dolutegravir (DTG) plus lamivudine (Arm 1) or continuation of their current regimen (Arm 2) for 48 weeks. The primary endpoint is virologic failure defined as confirmed plasma HIV-1 RNA \> 50 copies/mL before or at Week 24

HIV Infection

Babafemi Taiwo89 participantsStarted Dec 2014

San Diego, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +4 more locations

TERMINATEDPhase 12.2 miles

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

NCT03677960

This study evaluates the use of ABI-1968, a topical cream, in the treatment of anal precancerous lesions in adults with and without human immunodeficiency virus (HIV) infection

HSIL, High-Grade Squamous Intraepithelial LesionsHuman Papilloma Virus InfectionHIV Infection+2 more

Antiva Biosciences6 participantsStarted Dec 2018

Chicago, Illinois, United States • Darlinghurst, Sydney, Australia

COMPLETEDNA2.2 miles

Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART

NCT01751646

This is a 48 week randomized double-blind, placebo-controlled prospective cohort study of adolescents and young adults with HIV infection in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) who are currently being treated with cART that includes tenofovir disoproxil fumarate (TDF) as one component of the regimen that includes at least three Food and Drug Administration (FDA)-approved antiretroviral (ARV) drugs for at least 180 days.

HIV Infection

University of North Carolina, Chapel Hill214 participantsStarted Oct 2012

Los Angeles, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +14 more locations

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART

HIV/AIDS Trials in Other Cities

Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).

Fish Oil for HIV-Related Inflamm-aging and Immune Senescence

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Sevelamer for Reducing Endotoxemia and Immune Activation

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women

Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults

Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

Other Conditions in Chicago